Literature DB >> 20214021

Suppression of constitutively expressed cyclooxygenase-2 in the epididymis of mice by nimesulide decreases sperm motility.

Thotakura Balaji1, Subramanian Aruna, Manickam Ramanathan, Marimuthu Srinivasan, Venugopal Padmanabhan Menon.   

Abstract

Significant levels of constitutive cyclooxygenase-2 (COX-2) are present in the male reproductive organs of rodents, especially in the vas deferens and epididymis. In the epididymis, the sperm storehouse, COX-2 is thought to play a vital role in altering the membrane lipids of sperm. The present study aims at localizing COX-2 in the epididymis and analyzing the effects of the preferential COX-2 inhibitor nimesulide. COX-2 protein activity was nearly equal to that of COX-1 in the cauda epididymis. Immunohistochemical studies showed an intense staining for COX-2 in the cauda epididymis but not in the caput epididymis. Nimesulide administration induced a significant reduction in both COX-2 staining intensity and protein activity, followed by an initial decline in total prostaglandin levels but a reversible increase upon sustained COX-2 suppression. Sperm numbers and vitality showed no significant change, but motility decreased and total and free serum testosterone levels mildly increased.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20214021     DOI: 10.1515/jbcpp.2009.20.4.357

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  2 in total

1.  The immunobiology of the mammalian epididymis: the black box is now open!

Authors:  Rachel Guiton; Joelle Henry-Berger; Joël R Drevet
Journal:  Basic Clin Androl       Date:  2013-10-02

2.  Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environment.

Authors:  Aicha Jrad-Lamine; Joelle Henry-Berger; Christelle Damon-Soubeyrand; Fabrice Saez; Ayhan Kocer; Laurent Janny; Hanae Pons-Rejraji; David H Munn; Andrew L Mellor; Najoua Gharbi; Rémi Cadet; Rachel Guiton; Robert J Aitken; Joël R Drevet
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.